Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (121-130 of 471) with videos related to

Pageof 48
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Relationship between depth of response and outcome in multiple myelomaDavid Dingli, Jorge M Pacheco, Grzegorz S Nowakowski, et al.
Nephron|April 16, 2016
Total Red Blood Cell Transfusions for Chronic Hemodialysis Patients in a Single Center, 2009-2013Robert C Albright, John J Dillon, Craig L Hocum, et al.
British Journal of Cancer|July 13, 2016
Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapyYoichiro Yamamoto, Chetan P Offord, Go Kimura, et al.
British Journal of Haematology|December 5, 2009
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myelomaShirshendu Sinha, S Vincent Rajkumar, Martha Q Lacy, et al.
British Journal of Haematology|October 4, 2005
Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemiaAyalew Tefferi, Shireen Sirhan, Terra L Lasho, et al.
Future Oncology (London, England)|December 19, 2025
Real-world cardiac events and outcomes in cBTKi-treated chronic lymphocytic leukemia patientsDavid Dingli, Enrico De Nigris, Siyang Leng, et al.
Bone Marrow Transplantation|October 6, 2022
Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myelomaCharalampos Charalampous, Utkarsh Goel, Morie Gertz, et al.
Annals of Hematology|November 17, 2024
Health-related quality of life and symptom-specific functional impairment among patients treated with parenterally administered complement inhibitors for paroxysmal nocturnal hemoglobinuriaDavid Dingli, Avery A Rizio, Lynne Broderick, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 11, 2015
Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo ClinicMuhammad A Mir, Prashant Kapoor, Shaji Kumar, et al.
British Journal of Haematology|July 21, 2005
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasiaDavid Dingli, Francis H Grand, Victor Mahaffey, et al.
Pageof 48

Showing results (121-130 of 471) with videos related to

Sort By:
Pageof 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Relationship between depth of response and outcome in multiple myelomaDavid Dingli, Jorge M Pacheco, Grzegorz S Nowakowski, et al.
Nephron|April 16, 2016
Total Red Blood Cell Transfusions for Chronic Hemodialysis Patients in a Single Center, 2009-2013Robert C Albright, John J Dillon, Craig L Hocum, et al.
British Journal of Cancer|July 13, 2016
Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapyYoichiro Yamamoto, Chetan P Offord, Go Kimura, et al.
British Journal of Haematology|December 5, 2009
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myelomaShirshendu Sinha, S Vincent Rajkumar, Martha Q Lacy, et al.
British Journal of Haematology|October 4, 2005
Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemiaAyalew Tefferi, Shireen Sirhan, Terra L Lasho, et al.
Future Oncology (London, England)|December 19, 2025
Real-world cardiac events and outcomes in cBTKi-treated chronic lymphocytic leukemia patientsDavid Dingli, Enrico De Nigris, Siyang Leng, et al.
Bone Marrow Transplantation|October 6, 2022
Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myelomaCharalampos Charalampous, Utkarsh Goel, Morie Gertz, et al.
Annals of Hematology|November 17, 2024
Health-related quality of life and symptom-specific functional impairment among patients treated with parenterally administered complement inhibitors for paroxysmal nocturnal hemoglobinuriaDavid Dingli, Avery A Rizio, Lynne Broderick, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 11, 2015
Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo ClinicMuhammad A Mir, Prashant Kapoor, Shaji Kumar, et al.
British Journal of Haematology|July 21, 2005
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasiaDavid Dingli, Francis H Grand, Victor Mahaffey, et al.
Pageof 48